BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9442393)

  • 21. Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity.
    Annweiler A; Müller-Immerglück M; Wirth T
    Mol Cell Biol; 1992 Jul; 12(7):3107-16. PubMed ID: 1620119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells.
    Emslie D; D'Costa K; Hasbold J; Metcalf D; Takatsu K; Hodgkin PO; Corcoran LM
    J Exp Med; 2008 Feb; 205(2):409-21. PubMed ID: 18250192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Oct2-isoform expression in lipopolysaccharide-stimulated B lymphocytes.
    Johansson K; Sigvardsson M; Leanderson T
    Scand J Immunol; 1994 Jun; 39(6):526-32. PubMed ID: 8009171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catfish Oct2 binding affinity and functional preference for octamer motifs, and interaction with OBF-1.
    Ross DA; Lyles M; Ledford BE; Magor BG; Wilson MR; Miller NW; Clem LW; Middleton DA; Warr GW
    Dev Comp Immunol; 1999 Apr; 23(3):199-211. PubMed ID: 10402207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.
    Kaku H; Rothstein TL
    Genes Immun; 2010 Jan; 11(1):55-66. PubMed ID: 19710692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2.
    Hodson DJ; Shaffer AL; Xiao W; Wright GW; Schmitz R; Phelan JD; Yang Y; Webster DE; Rui L; Kohlhammer H; Nakagawa M; Waldmann TA; Staudt LM
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2039-46. PubMed ID: 26993806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The MYC-regulated lncRNA LNROP (ENSG00000254887) enables MYC-driven cell proliferation by controlling the expression of OCT2.
    García-Caballero D; Hart JR; Vogt PK
    Cell Death Dis; 2023 Feb; 14(2):168. PubMed ID: 36849510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human CRISP-3 binds serum alpha(1)B-glycoprotein across species.
    Udby L; Johnsen AH; Borregaard N
    Biochim Biophys Acta; 2010 Apr; 1800(4):481-5. PubMed ID: 20116414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eukaryotic expression, purification and structure/function analysis of native, recombinant CRISP3 from human and mouse.
    Volpert M; Mangum JE; Jamsai D; D'Sylva R; O'Bryan MK; McIntyre P
    Sci Rep; 2014 Feb; 4():4217. PubMed ID: 24573035
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Leng D; Miao R; Huang X; Wang Y
    Oncol Lett; 2018 Apr; 15(4):5167-5174. PubMed ID: 29552153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolutionary Rewiring of Human Regulatory Networks by Waves of Genome Expansion.
    Marnetto D; Mantica F; Molineris I; Grassi E; Pesando I; Provero P
    Am J Hum Genet; 2018 Feb; 102(2):207-218. PubMed ID: 29357977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oct2 and Obf1 as Facilitators of B:T Cell Collaboration during a Humoral Immune Response.
    Corcoran L; Emslie D; Kratina T; Shi W; Hirsch S; Taubenheim N; Chevrier S
    Front Immunol; 2014; 5():108. PubMed ID: 24688485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers.
    La Rocca G; Anzalone R; Corrao S; Magno F; Loria T; Lo Iacono M; Di Stefano A; Giannuzzi P; Marasà L; Cappello F; Zummo G; Farina F
    Histochem Cell Biol; 2009 Feb; 131(2):267-82. PubMed ID: 18836737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cell development and immunoglobulin transcription in Oct-1-deficient mice.
    Wang VE; Tantin D; Chen J; Sharp PA
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2005-10. PubMed ID: 14762167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice.
    Wang VE; Schmidt T; Chen J; Sharp PA; Tantin D
    Mol Cell Biol; 2004 Feb; 24(3):1022-32. PubMed ID: 14729950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of target genes of the lymphoid-specific transcription factor Oct2.
    Pfisterer P; Hess J; Wirth T
    Immunobiology; 1997 Dec; 198(1-3):217-26. PubMed ID: 9442393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2.
    Pfisterer P; König H; Hess J; Lipowsky G; Haendler B; Schleuning WD; Wirth T
    Mol Cell Biol; 1996 Nov; 16(11):6160-8. PubMed ID: 8887646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Oct2 from the channel catfish: functional preference for a variant octamer motif.
    Ross DA; Magor BG; Middleton DL; Wilson MR; Miller NW; Clem LW; Warr GW
    J Immunol; 1998 Apr; 160(8):3874-82. PubMed ID: 9558093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular principles of Oct2-mediated gene activation in B cells.
    Wirth T; Pfisterer P; Annweiler A; Zwilling S; König H
    Immunobiology; 1995 Jul; 193(2-4):161-70. PubMed ID: 8530140
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.